Amrize, CH1430134226

Amrize stock: JPMorgan cuts price target to 46 US dollars

Published on 11/21/2026 at 11:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amrize stock drew a lower valuation target from JPMorgan on November 19. The bank kept its Neutral rating after updating its model following third-quarter results.

Analysten senken ihre Kursziele

  • JPMorgan hält an der Neutral-Einstufung für Amrize fest.
  • Die Anpassung folgte einer Aktualisierung des Modells nach den Ergebnissen des dritten Quartals.
Amrize, CH1430134226, Illustration mit AI erstellt.

JPMorgan lowered its price target for Amrize from 48 to 46 US dollars on November 19 while keeping a Neutral rating on the shares. Markets Insider reported that the bank updated its model after Amrize's third-quarter results.

JPMorgan recalibrates its outlook

The change leaves JPMorgan's Neutral view intact but reduces its stated valuation target by 2 US dollars. For investors, the revision puts the bank's updated assessment of Amrize's earnings outlook in focus rather than changing its formal rating.

Amrize stock traded at 35.88 euros on Lang & Schwarz at 11:18 CET on Saturday, November 21.

Amrize company and market details

  • Company: Amrize AG
  • ISIN: CH1430134226
  • Ticker: AMRZ
  • Latest quote: 35.88 euros on Lang & Schwarz, Saturday, November 21, 2026, at 11:18 CET

Global equity markets remain the broader setting for construction and building-materials shares; see Current market reports.

More company news and analysis is available in More news and analyses on Amrize stock.

Disclaimer...
en | CH1430134226 | AMRIZE | boerse | 70542044 | bgmi